1. Home
  2. News
  3. Dr. Reddy's Laboratories Ltd.
  4. Press Release Jul 08 2022
More Dr. Reddy's Laboratories Ltd. news
Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Jul 08 2022

Jul 8, 2022 at 5:37 PM EDT · Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE · Jul 8, 2022 at 5:37 PM EDT

On 6ix: 6ix.com/news/press-release-jul-08-2022-1

Watch Dr. Reddy's Laboratories' latest call↗Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call↗

Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 08-Jul-2022 titled Dr. Reddy's Laboratories announces the launch of Fesoterodine Fumarate Extended-Release Tablets in the U.S. market

View Attachment

6ix hasn’t read this filing yet.

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

  • Press Release Jun 28 2022Jun 28, 2022
  • Press Release Jun 24 2022Jun 24, 2022
  • Dr. Reddy's Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton PharmaJun 24, 2022
  • Press Release Jun 14 2022Jun 14, 2022
  • Press Release Jun 09 2022Jun 9, 2022

Later from Dr. Reddy's Laboratories

  • Press Release Jul 22 2022Jul 22, 2022
  • Press Release Jul 27 2022Jul 27, 2022
  • Press Release Sep 07 2022Sep 7, 2022
  • Press Release Oct 11 2022Oct 11, 2022
  • Press Release Dec 16 2022Dec 16, 2022
All Dr. Reddy's Laboratories news releases↗

Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.

Follow Dr. Reddy's Laboratories
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer